A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration
Open accessAbstract
Evidence suggests that amyloid β is highly toxic to synapses in a phospho-Tau-dependent manner. Here, I present a hypothesis that links previous evidence from the first rise of amyloid β through to Tau tangles and neurodegeneration. In the immediate vicinity of plaques, concentrated soluble amyloid β occurs in equilibrium with deposited forms. Initially, plaques cover only a small percentage of brain volume. Microglia, by efficiently removing damaged synapses, may prevent spread of damage along the axon, restricting damage to the immediate vicinity of plaques. However, as plaque load increases, as seen in Alzheimer's disease, an individual axon may suffer multiple points of damage, leading to dissociation of Tau, formation of a tangle, and loss of the axon. As more axons suffer this fate, the network eventually degenerates. According to this hypothesis, the degree of plaque load that an individual can tolerate would depend on the efficiency of their microglia in removing amyloid-β-damaged synapses and the distribution of plaques, relative to axon trajectories, would determine the eventual cognitive symptoms.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Engagement of anti-inflammatory pathways may contribute to the resistance of mice with a heavy amyloid load from developing the full AD pathology of Tau tangles and neurodegeneration.
“preferentially involves engagement of anti-inflammatory pathways that may contribute to the resistance of mice with a heavy amyloid load from developing the full AD pathology of Tau tangles and neurodegeneration”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [104]
Increased expression of TREM2 in Alzheimer's disease has a protective function slowing disease progression.
“Our findings are thus compatible with increased expression of TREM2 in Alzheimer’s disease having a protective function slowing disease progression”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [104]
Loss of function due to the presence of the Trem2 R47H mutation increases the chance of AD reaching the stage of diagnosis.
“loss of function due to the presence of the Trem2 R47H mutation increasing the chance of AD reaching the stage of diagnosis (44,104–107)”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 88 · Cited by 140
- Authors
- Edwards, F. A.
- Affiliations
- University College London (GB)
- Corresponding author
- Edwards, Frances A.
- ORCID
- Edwards, Frances A.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 42
- Issue
- 5
- Pages
- 310-322
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2936535041
- Cited by
- 140
- References
- 88
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 32 · 2020: 23 · 2019: 6
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Alzheimer’s Research UK
- The UK Dementia Research Institute
- The Cure Alzheimer’s
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, phosphorylated tau, tau tangles, neurodegeneration, amyloid plaques, microglia, axonal injury, cognitive decline
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, Disease Progression, Neurodegenerative Diseases, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review